Prevalence of hepatitis B and C serological markers among first‐time blood donors in Brazil: A multi‐center serosurvey
Open Access
- 26 November 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 80 (1) , 53-57
- https://doi.org/10.1002/jmv.21046
Abstract
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (HBV and HCV) infection in Latin American countries. A multi‐center serosurvey was conducted among 3,598 first‐time blood donors (65% men) from Sao Paulo, Salvador and Manaus in Brazil. The gender‐specific seroprevalences of antibodies against hepatitis B core antigen (anti‐HBc) and of the hepatitis B surface antigen (HBsAg) in anti‐HBc‐positive sera were measured, and risk factors analyzed by gender. The gender‐specific seroprevalences of antibodies against HCV (anti‐HCV) were measured, but risk factors for HCV were not determined. Anti‐HBc and HBsAg seroprevalences were not significantly different in men [101/2,341 (4.31%) and 4/2,229 (0.18%), respectively] and women [65/1,237 (5.25%) and 8/1,169 (0.68%), respectively], whereas the seroprevalence of anti‐HCV was higher in women (12/1,238 [0.97%] vs. 9/2,353 [0.38%]; odds ratio [OR] = 2.49; 95% confidence interval [CI]: 1.0–6.0). No significant difference for HBV infection was found across the three study sites or by ethnic group. The seroprevalence of anti‐HBc increased with age, but decreased with education level in both genders. Lifetime number of sexual partners was associated with anti‐HBc prevalence among men (OR = 1.95; 95% CI: 1.2–3.1), but not women. The seroprevalence of HBV and HCV was low among Brazilian blood donors, and exposure increased with age in both genders. J. Med. Virol. 80:53–57, 2008.Keywords
This publication has 19 references indexed in Scilit:
- Anti–hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practiceTransfusion, 2006
- Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitisCurrent Medical Research and Opinion, 2006
- Chronic hepatitis B: current epidemiology in the Americas and implications for managementJournal of Viral Hepatitis, 2006
- Prevalence and screening costs of hepatitis C virus among Ugandan blood donorsTropical Medicine & International Health, 2006
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Ocorrência da infecção pelo vírus da hepatite B (VHB) e delta (VHD) em sete grupos indígenas do Estado do AmazonasRevista da Sociedade Brasileira de Medicina Tropical, 2001
- Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989–1996Vaccine, 2000
- Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.American Journal of Public Health, 1999
- Risk Factors and Anti‐HBc Reactivity among First Time Blood DonorsVox Sanguinis, 1997